Seuraa
Debora Collotta
Debora Collotta
PhD
Vahvistettu sähköpostiosoite verkkotunnuksessa unito.it
Nimike
Viittaukset
Viittaukset
Vuosi
Pharmacological inhibition of NLRP3 inflammasome attenuates myocardial ischemia/reperfusion injury by activation of RISK and mitochondrial pathways
R Mastrocola, C Penna, F Tullio, S Femminò, D Nigro, F Chiazza, L Serpe, ...
Oxidative Medicine and Cellular Longevity 2016 (1), 5271251, 2016
1412016
Fructose liquid and solid formulations differently affect gut integrity, microbiota composition and related liver toxicity: a comparative in vivo study
R Mastrocola, I Ferrocino, E Liberto, F Chiazza, AS Cento, D Collotta, ...
The Journal of Nutritional Biochemistry 55, 185-199, 2018
802018
Inhibition of Bruton's TK regulates macrophage NF‐κB and NLRP3 inflammasome activation in metabolic inflammation
GSD Purvis, M Collino, H Aranda‐Tavio, F Chiazza, CE O'Riordan, ...
British journal of pharmacology 177 (19), 4416-4432, 2020
742020
Identification of AnnexinA1 as an endogenous regulator of RhoA, and its role in the pathophysiology and experimental therapy of type-2 diabetes
GSD Purvis, M Collino, RA Loiola, A Baragetti, F Chiazza, M Brovelli, ...
Frontiers in Immunology 10, 571, 2019
642019
Effects of exogenous dietary advanced glycation end products on the cross-talk mechanisms linking microbiota to metabolic inflammation
R Mastrocola, D Collotta, G Gaudioso, M Le Berre, AS Cento, ...
Nutrients 12 (9), 2497, 2020
612020
Antisense oligonucleotides: A novel Frontier in pharmacological strategy
D Collotta, I Bertocchi, E Chiapello, M Collino
Frontiers in Pharmacology 14, 1304342, 2023
602023
Ribonuclease 1 attenuates septic cardiomyopathy and cardiac apoptosis in a murine model of polymicrobial sepsis
E Zechendorf, CE O’Riordan, L Stiehler, N Wischmeyer, F Chiazza, ...
JCI insight 5 (8), e131571, 2020
482020
Bruton's tyrosine kinase inhibition attenuates the cardiac dysfunction caused by cecal ligation and puncture in mice
CE O'Riordan, GSD Purvis, D Collotta, F Chiazza, B Wissuwa, S Al Zoubi, ...
Frontiers in Immunology 10, 2129, 2019
452019
The hidden role of NLRP3 inflammasome in obesity‐related COVID‐19 exacerbations: lessons for drug repurposing
I Bertocchi, F Foglietta, D Collotta, C Eva, V Brancaleone, C Thiemermann, ...
British journal of pharmacology 177 (21), 4921-4930, 2020
412020
Linagliptin attenuates the cardiac dysfunction associated with experimental sepsis in mice with pre-existing type 2 diabetes by inhibiting NF-κB
S Al Zoubi, J Chen, C Murphy, L Martin, F Chiazza, D Collotta, ...
Frontiers in immunology 9, 2996, 2018
382018
X-linked immunodeficient mice with no functional Bruton's tyrosine kinase are protected from sepsis-induced multiple organ failure
CE O'Riordan, GSD Purvis, D Collotta, N Krieg, B Wissuwa, MH Sheikh, ...
Frontiers in immunology 11, 581758, 2020
322020
RvE1 attenuates polymicrobial sepsis-induced cardiac dysfunction and enhances bacterial clearance
J Chen, GSD Purvis, D Collotta, S Al Zoubi, MA Sugimoto, A Cacace, ...
Frontiers in immunology 11, 2080, 2020
312020
Baricitinib counteracts metaflammation, thus protecting against diet-induced metabolic abnormalities in mice
D Collotta, W Hull, R Mastrocola, F Chiazza, AS Cento, C Murphy, R Verta, ...
Molecular Metabolism 39, 101009, 2020
282020
Ticagrelor conditioning effects are not additive to cardioprotection induced by direct NLRP3 inflammasome inhibition: role of RISK, NLRP3, and redox cascades
C Penna, M Aragno, AS Cento, S Femminò, I Russo, FD Bello, F Chiazza, ...
Oxidative medicine and cellular longevity 2020 (1), 9219825, 2020
282020
Protective Effects of Pyridoxamine Supplementation in the Early Stages of Diet‐Induced Kidney Dysfunction
F Chiazza, AS Cento, D Collotta, D Nigro, G Rosa, F Baratta, V Bitonto, ...
BioMed research international 2017 (1), 2682861, 2017
262017
Resolvin D1 attenuates the organ injury associated with experimental hemorrhagic shock
R Sordi, F Chiazza, D Collotta, G Migliaretti, RA Colas, P Vulliamy, ...
Annals of surgery 273 (5), 1012-1021, 2021
252021
Pharmacological inhibition of FAK-Pyk2 pathway protects against organ damage and prolongs the survival of septic mice
GF Alves, E Aimaretti, G Einaudi, R Mastrocola, JG de Oliveira, D Collotta, ...
Frontiers in Immunology 13, 837180, 2022
192022
In Vitro Evaluation of the Toxicological Profile and Oxidative Stress of Relevant Diet‐Related Advanced Glycation End Products and Related 1, 2‐Dicarbonyls
V Cepas, F Manig, JC Mayo, M Hellwig, D Collotta, V Sanmartino, ...
Oxidative medicine and cellular longevity 2021 (1), 9912240, 2021
192021
Altered hepatic sphingolipid metabolism in insulin resistant mice: Role of advanced glycation endproducts
R Mastrocola, F Dal Bello, AS Cento, K Gaens, D Collotta, M Aragno, ...
Free Radical Biology and Medicine 169, 425-435, 2021
162021
Recent advances in JAK inhibitors for the treatment of metabolic syndrome
D Collotta, MP Franchina, V Carlucci, M Collino
Frontiers in Pharmacology 14, 1245535, 2023
152023
Järjestelmä ei voi suorittaa toimenpidettä nyt. Yritä myöhemmin uudelleen.
Artikkelit 1–20